Name
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
MGI ID
MGI:1298392
Synonyms
seipin
Gng3lg
Viability
Embryo viewer
Significant
Not Significant
Not tested
| Phenotype | System | Allele | Zyg | Sex | Life Stage | P Value |
|---|---|---|---|---|---|---|
| increased circulating serum albumin level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 0.00 | ||
| increased circulating alkaline phosphatase level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 3.72×10-10 | ||
| increased circulating phosphate level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 9.00×10-09 | ||
| improved glucose tolerance | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.74×10-05 | ||
| increased mean platelet volume | Bscl2em1(IMPC)H | HET | Early adult | 7.33×10-05 | ||
| increased circulating total protein level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 0.00 | ||
| decreased blood urea nitrogen level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.24×10-05 | ||
| decreased total body fat amount | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 5.75×10-10 | ||
| decreased eosinophil cell number | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 4.80×10-06 | ||
| increased fluid intake | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.97×10-06 | ||
| increased monocyte cell number | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 9.95×10-06 | ||
| increased mean corpuscular hemoglobin | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.05×10-11 | ||
| decreased prepulse inhibition | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 3.55×10-06 | ||
| decreased total retina thickness | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 3.61×10-05 | ||
| decreased erythrocyte cell number | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 8.27×10-05 | ||
| increased leukocyte cell number | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 4.20×10-06 | ||
| abnormal bone structure | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.90×10-10 | ||
| short tibia | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 4.35×10-10 | ||
| decreased body length | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 8.58×10-10 | ||
| increased lean body mass | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 0.00 | ||
| increased cornea thickness | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 3.07×10-12 | ||
| decreased respiratory quotient | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 2.47×10-06 | ||
| decreased circulating triglyceride level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 2.64×10-09 | ||
| decreased bone mineral content | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.58×10-05 | ||
| increased circulating calcium level | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 0.00 | ||
| abnormal gait | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 1.29×10-09 | ||
| decreased vertical activity | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 9.19×10-05 | ||
| increased mean corpuscular volume | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 9.84×10-12 | ||
| abnormal cholesterol homeostasis | Bscl2tm1b(EUCOMM)Hmgu | HOM | Early adult | 3.31×10-05 |
Select physiological systems to view:
Viewing: all phenotypes
Select physiological systems to view:
Viewing: all phenotypes
